National Aeronautics and Space Administration September 3, 2019 – Federal Register Recent Federal Regulation Documents

NASA hereby gives notice of its intent to grant a partially exclusive patent license in the United States to practice the invention described and claimed in U.S. Patent Number 7,381,186 B2, titled ``Method and Apparatus to Assess Compartment Syndrome,'' NASA Case Number LAR-16854-1, to Aspire MedTech Inc. having its principal place of business in Tampa Bay, Florida. The fields of use may be limited to devices to assess compartment syndrome and/or similar field(s) of use thereto. NASA has not yet made a determination to grant the requested license and may deny the requested license even if no objections are submitted within the comment period.

Under the provisions of the Paperwork Reduction Act, the Regulatory Secretariat Division has submitted to the Office of Management and Budget (OMB) a request to review and approve a revision and renewal of a previously approved information collection requirement concerning limitation of costs/funds.